To investigate whether silencing of PD-L1 on cancer cells promotes proliferation of tumor-specific CTLs, we re-stimulated OVA-specific CD8+ T cells and transfected Blue-OVA cells with siPD-L1@PLGA NPs in the manner described above. Here, CD8A is linked to cancer.